---
title: Carbogen Amcis vs Siegfried Holding
slug_a: carbogen-amcis
slug_b: siegfried
site: cdmo
review_signal_gate: closed
canonical_path: /compare/carbogen-amcis/siegfried
---

# Carbogen Amcis vs Siegfried Holding

Side-by-side profile data from each company listing on this directory.

## Carbogen Amcis

- Profile: [/companies/carbogen-amcis](/companies/carbogen-amcis)

Carbogen Amcis — Full-service CDMO offering integrated drug substance and sterile drug product development and manufacturing from early phase through commercialization, with specialized capabilities in API synthesis, process development, analytical services, and stability testing across multiple scales.

Services: 18. Modalities: 2. Indications: 0. Locations: 14. Certifications: 5. The strongest documented coverage currently appears in services (18).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Flow Chemistry & Continuous Manufacturing
- Solid-State Chemistry & Polymorph Screening
- ADC (Antibody-Drug Conjugate) Manufacturing
- ADC Payload & Linker Synthesis
- Bioconjugation Services
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Lyophilization (Freeze Drying)
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Antibody-Drug Conjugate (ADC)

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing
- Solid-state characterization

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Lyophilized Vials
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI
- Flow Chemistry
- Hydrogenation
- Cryogenic (−80 °C)

## Siegfried Holding

- Profile: [/companies/siegfried](/companies/siegfried)

Siegfried Holding — Global CDMO with 16 production sites across four continents, offering integrated development and manufacturing from early-phase to commercial scale for drug substance and drug product.

Services: 18. Modalities: 2. Indications: 0. Locations: 6. Certifications: 4. The strongest documented coverage currently appears in services (18).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Controlled Substance Manufacturing
- Flow Chemistry & Continuous Manufacturing
- Viral Vector Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Oral Solid Dosage Manufacturing
- Inhalation & Nasal Dosage Manufacturing
- Ophthalmic Manufacturing
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Cold-Chain Storage & Logistics
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Gene Therapy

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Oral Solid Dose (OSD)
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI
- DEA licensed
- Hydrogenation
- Cryogenic (−80 °C)
- Flow Chemistry